Gallbladder Cancer

Gallbladder cancer, though uncommon, is a particularly aggressive form of cancer that begins in the cells lining the gallbladder. Cutting-edge research has been dedicated to uncovering the genetic mutations and molecular mechanisms that drive this disease. Advances in imaging technologies and biomarker identification have become pivotal for early diagnosis. Genomic sequencing has revealed critical mutations in genes such as TP53, KRAS, and ERBB2, paving the way for targeted treatments. Additionally, novel therapies, including immunotherapy, are showing promise in improving patient outcomes. Ongoing research efforts are essential to develop effective diagnostic and therapeutic approaches for this formidable cancer.